Christian Roesky

Christian Roesky, Dr. is a seasoned executive with extensive experience in the pharmaceutical and diagnostics industries. Since November 2016, Christian Roesky has served as the Chief Executive Officer and Managing Director of Novaliq GmbH, a specialty pharmaceutical company focused on innovative water-free ophthalmics. Christian Roesky also holds board positions at Dermaliq Therapeutics, Inc. and Betaliq Inc., and serves as a Director at Novaliq Inc. Previous roles include General Manager at Bausch + Lomb and Alcon, as well as Managing Director for Abbott's Diagnostics Division in Central Europe. Christian Roesky earned a Ph.D. in Chemistry from TU Bergakademie Freiberg and a Diplom in Chemistry from The University of Bonn.